US regulators demand more OTC derivatives data

During the initial session of the second day of the US Financial Crisis Inquiry Commission, regulators requested that more information on OTC derivatives transactions be made available to supervisors.

US Securities and Exchange Commission chairman Mary Schapiro told the enquiry: "To prevent bad actors from hiding their trading activities, the SEC needs the tools to effectively apply the securities laws and police the securities-based derivatives market. Right now, the SEC is responsible for

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: